Related Experiment Video
Updated: Jun 9, 2025

05:38
The Chick Chorioallantoic Membrane CAM Model as a Tool to Study Ovarian Tissue Transplantation
Published on: June 23, 2023
822
Implementing Chicken Chorioallantoic Membrane (CAM) Assays for Validating Biomaterials in Tissue Engineering:
Mélanie Dhayer1, Amélia Jordao1,2, Salim Dekiouk1,3
1ONCOLILLE Cancer Institute - CANTHER Laboratory "Cancer Heterogeneity, Plasticity and Resistance to Therapies", Lille, France.
Summary
The chicken chorioallantoic membrane (CAM) assay offers an efficient, ethical, and economical in vivo model for preclinical screening of biomaterials in tissue engineering. This guide details its implementation for assessing biocompatibility and angiogenesis before further in vivo studies.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- In Vivo Models
Background:
- Tissue engineering aims to generate or repair living tissues, requiring innovative biomaterials for clinical applications.
- Preclinical testing is crucial for ensuring the safety and performance of biomaterials before clinical use.
- Existing methods for biomaterial testing can be limited by ethical and economic factors.
Purpose of the Study:
- To highlight the advantages of the chicken chorioallantoic membrane (CAM) assay as a screening tool for tissue engineering biomaterials.
- To provide a comprehensive, step-by-step guide for implementing the CAM assay in research laboratories.
- To showcase examples of biomaterials successfully screened using the CAM assay.
Main Methods:
- The study focuses on the chicken chorioallantoic membrane (CAM) assay, an established in vivo model.
- Detailed protocols, tips, and tricks for conducting CAM assays are provided.
- Examples of biomaterial screening using the CAM assay are presented.
Main Results:
- The CAM assay serves as a preferred, high-throughput screening tool for biomaterial biocompatibility, angiogenesis, and inflammation.
- It offers ethical and economic advantages over other preclinical testing methods.
- The assay is effective for assessing the angiogenic potential of tissue-engineered scaffolds.
Conclusions:
- The CAM assay is a powerful in vivo model for the preclinical evaluation of biomaterials in tissue engineering.
- This guide provides a framework for assay implementation, adaptable to specific research needs.
- Optimizing experimental conditions is key for successful biomaterial screening using the CAM assay.

